SNHG1: Redefining the Landscape of Hepatocellular Carcinoma through Long Noncoding RNAs

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality globally.
• Current biomarkers like alpha-fetoprotein lack sufficient sensitivity and specificity for early HCC detection and management.
• Improved diagnostic and prognostic approaches are crucial for enhancing patient survival rates.

Purpose of the Study:

• To review the multifaceted roles of SNHG1 in hepatocellular carcinoma (HCC) pathogenesis.
• To highlight the clinicopathological correlations of SNHG1 expression in HCC.
• To evaluate the potential of SNHG1 as a biomarker for HCC diagnosis and prognosis.

Main Methods:

• Comprehensive literature review of studies investigating SNHG1 in HCC.
• Analysis of SNHG1's molecular functions, including its regulation of cellular processes.
• Examination of clinical data correlating SNHG1 expression with HCC patient outcomes.

Main Results:

• SNHG1 is consistently upregulated in HCC tissues and cell lines.
• SNHG1 regulates key tumorigenic processes: cell division, angiogenesis, apoptosis, metabolism, and immune cell interaction.
• Elevated SNHG1 expression correlates with larger, poorly differentiated, aggressive tumors, advanced stages, and reduced overall survival in HCC patients.

Conclusions:

• SNHG1 plays a significant role in HCC development and progression.
• SNHG1 expression levels are closely linked to clinical outcomes in HCC patients.
• SNHG1 shows promise as a potential biomarker for improving HCC diagnosis and prognosis.